发明名称 Antiviral N-(acylribofuranosyl)-1,2,4-triazole-3-(thio)carboxamides
摘要 Triazole derivs. of formulae (I) and (II) are new: (R1=CONH2, CSNH2 or C(NH)NH2 (and the physiologically acceptable acid addn. salts thereof); X=Hor 1-18C acyl at least one X is H and at least one is acyl; R = H or 1-18C acyl). Also claimed are teh hydrolysis prods. of (II). i.e. a mixt. of corresp. 2'-and 3'-monophosphates. Cpds. are antivirals. In a trial swiss mice were infected with 3.2 LD50 doses of influenza A2 virus (Japan 305). Only 1 untreated mouse of 20 survived (survival time 7.1 days) while mice give 300 mg/kg/day of 1-(5-butyryl-beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide survived 9.6 days (5 out of 10 survivors.
申请公布号 ES8800256(A3) 申请公布日期 1988.01.01
申请号 ES19550007289 申请日期 1987.01.09
申请人 VIRATEK, INC. 发明人
分类号 A61K31/70;C07H19/056;(IPC1-7):C07H19/056 主分类号 A61K31/70
代理机构 代理人
主权项
地址